Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 3.195M
February 28, 2026 3.029M
November 30, 2025 2.948M
August 31, 2025 2.815M
May 31, 2025 2.546M
February 28, 2025 2.546M
November 30, 2024 18.34M
August 31, 2024 16.82M
May 31, 2024 16.82M
February 29, 2024 16.82M
November 30, 2023 16.82M
August 31, 2023 16.82M
May 31, 2023 16.82M
February 28, 2023 13.49M
November 30, 2022 1.685M
August 31, 2022 13.41M
May 31, 2022 12.87M
February 28, 2022 12.85M
November 30, 2021 12.69M
August 31, 2021 12.51M
May 31, 2021 1.538M
February 28, 2021 1.538M
November 30, 2020 1.471M
August 31, 2020 1.469M
May 31, 2020 11.74M
Date Value
February 29, 2020 10.31M
November 30, 2019 9.851M
August 31, 2019 9.769M
May 31, 2019 9.677M
February 28, 2019 9.334M
November 30, 2018 9.289M
August 31, 2018 8.954M
May 31, 2018 8.888M
February 28, 2018 8.622M
November 30, 2017 8.530M
August 31, 2017 8.512M
May 31, 2017 8.511M
February 28, 2017 8.505M
November 30, 2016 8.300M
August 31, 2016 8.170M
May 31, 2016 8.170M
February 29, 2016 7.659M
November 30, 2015 7.590M
August 31, 2015 7.584M
May 31, 2015 7.567M
February 28, 2015 7.555M
November 30, 2014 7.553M
August 31, 2014 7.552M
May 31, 2014 7.544M
February 28, 2014 7.514M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Univec, Inc. 2.523B
Lantheus Holdings, Inc. 65.26M
Zomedica Corp. 979.95M
IDEXX Laboratories, Inc. 78.87M
Neogen Corp. 217.70M